In the present work, we aimed to delineate the effects of mono- and combinatorial pre-treatment upon neurological status and neurological integrity biomarkers, namely protein S100b, GFAP, procalcitonin, and galectin-3, following a cerebrovascular accident. This evidence concerns the gene S100B and stroke disorder.